XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Class A common stock not subject to possible redemption
Common Stock
Class B Common Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2020   $ 1,725 $ 23,275 $ (1,519) $ 23,481
Beginning balance (in shares) at Dec. 31, 2020   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Sale of 9,800,000 Private Placement Warrants     686,000   686,000
Accretion for Class A common stock subject to redemption amount     (709,275) (53,037,984) (53,747,259)
Net income (loss)       (11,644,456) (11,644,456)
Ending balance at Mar. 31, 2021   $ 1,725   (64,683,959) (64,682,234)
Ending balance (in shares) at Mar. 31, 2021   17,250,000      
Beginning balance at Dec. 31, 2020   $ 1,725 23,275 (1,519) 23,481
Beginning balance (in shares) at Dec. 31, 2020   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Net income (loss)         (2,394,495)
Ending balance at Sep. 30, 2021   $ 1,725   (55,433,998) (55,432,273)
Ending balance (in shares) at Sep. 30, 2021   17,250,000      
Beginning balance at Mar. 31, 2021   $ 1,725   (64,683,959) (64,682,234)
Beginning balance (in shares) at Mar. 31, 2021   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Net income (loss)       3,617,812 3,617,812
Ending balance at Jun. 30, 2021   $ 1,725   (61,066,147) (61,064,422)
Ending balance (in shares) at Jun. 30, 2021   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Net income (loss)       5,632,149 5,632,149
Ending balance at Sep. 30, 2021   $ 1,725   (55,433,998) (55,432,273)
Ending balance (in shares) at Sep. 30, 2021   17,250,000      
Beginning balance at Dec. 31, 2021 $ 0 $ 1,725 0 (45,638,008) (45,636,283)
Beginning balance (in shares) at Dec. 31, 2021 0 17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Net income (loss)     0 4,281,904 4,281,904
Ending balance at Mar. 31, 2022   $ 1,725 0 (41,356,104) (41,354,379)
Ending balance (in shares) at Mar. 31, 2022   17,250,000      
Beginning balance at Dec. 31, 2021 $ 0 $ 1,725 0 (45,638,008) (45,636,283)
Beginning balance (in shares) at Dec. 31, 2021 0 17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Net income (loss)         15,451,307
Ending balance at Sep. 30, 2022   $ 1,725 0 (33,095,297) (33,093,572)
Ending balance (in shares) at Sep. 30, 2022   17,250,000      
Beginning balance at Mar. 31, 2022   $ 1,725 0 (41,356,104) (41,354,379)
Beginning balance (in shares) at Mar. 31, 2022   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Accretion for Class A common stock subject to redemption amount     0 (1,055,412) (1,055,412)
Net income (loss)     0 8,358,380 8,358,380
Ending balance at Jun. 30, 2022   $ 1,725 0 (34,053,136) (34,051,411)
Ending balance (in shares) at Jun. 30, 2022   17,250,000      
Increase (Decrease) in Shareholders' (Deficit) Equity          
Accretion for Class A common stock subject to redemption amount     0 (1,853,184) (1,853,184)
Net income (loss)     0 2,811,023 2,811,023
Ending balance at Sep. 30, 2022   $ 1,725 $ 0 $ (33,095,297) $ (33,093,572)
Ending balance (in shares) at Sep. 30, 2022   17,250,000